Scholars@Duke publication: Re-excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease

Re-excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease

Publication , Conference

Traweek, R; Martin, AN; Guadagnolo, BA; Bishop, AJ; Lazar, AJ; Bird, JE; Keung, EZ; Torres, KE; Hunt, KK; Feig, BW; Roland, CL; Scally, CP

Published in: ANNALS OF SURGICAL ONCOLOGY

2022

ANNALS OF SURGICAL ONCOLOGY

1534-4681

1068-9265

2022

SUPPL 2

400 / 400

APA

Chicago

ICMJE

MLA

NLM

Traweek, R., Martin, A. N., Guadagnolo, B. A., Bishop, A. J., Lazar, A. J., Bird, J. E., … Scally, C. P. (2022). Re-excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease. In ANNALS OF SURGICAL ONCOLOGY (Vol. 29, pp. 400–400).

Traweek, Raymond, Allison N. Martin, B Ashleigh Guadagnolo, Andrew J. Bishop, Alexander J. Lazar, Justin E. Bird, Emily Z. Keung, et al. “Re-excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease.” In ANNALS OF SURGICAL ONCOLOGY, 29:400–400, 2022.

Traweek R, Martin AN, Guadagnolo BA, Bishop AJ, Lazar AJ, Bird JE, Keung EZ, Torres KE, Hunt KK, Feig BW, Roland CL, Scally CP. Re-excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease. ANNALS OF SURGICAL ONCOLOGY. 2022. p. 400–400.

ANNALS OF SURGICAL ONCOLOGY

1534-4681

1068-9265

2022

SUPPL 2

400 / 400